Related Experiment Video
Updated: Oct 17, 2025

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Leukocytoclastic Vasculitis: Depiction of the Diagnostic Dilemma
Siddharth Bhesania1,2, Karanrajsinh Raol3, Chanoa Medina2,4
1Internal Medicine, Overlook Medical Center, Summit, USA.
Insights
Leukocytoclastic vasculitis (LCV) is a small vessel inflammation. A case study identified Bactrim DS as a likely trigger for LCV in an elderly patient, despite corticosteroid use, highlighting potential gaps in understanding vasculitis pathogenesis.
Area of Science:
- Immunology
- Dermatology
- Pathology
Background:
- Vasculitis classification depends on blood vessel size.
- Leukocytoclastic vasculitis (LCV) involves small vessel inflammation, affecting capillaries and venules.
- Numerous causes of LCV exist, both primary and secondary.
Observation:
- An 86-year-old male with idiopathic pulmonary fibrosis (IPF) and chronic corticosteroid use presented with non-blanchable purpura.
- The patient was recently prescribed Bactrim DS (trimethoprim-sulfamethoxazole) for Pneumocystis pneumonia prophylaxis.
- Sepsis secondary to urinary tract infection (UTI) and bacteremia was also noted.
Findings:
- A skin biopsy confirmed LCV.
- Bactrim DS was identified as the probable causative agent of LCV.
- LCV occurred despite chronic corticosteroid therapy, challenging expectations of immunosuppression.
Implications:
- This case suggests potential dose-dependent effects of corticosteroids or limitations in understanding their immunosuppressive mechanisms in LCV.
- Further research is needed to elucidate the causes and pathogenesis of LCV.
- The findings underscore the importance of considering drug-induced vasculitis even in patients on immunosuppressive therapy.
Abstract:
Vasculitis is classified based on the size of the blood vessels involved. Sub-group Leukocytoclastic vasculitis (LCV) refers to small blood vessel inflammation, which involves cutaneous capillaries and venules. To date, there have been myriad primary and secondary probable causes of LCV. Here, we present a case of an 86-year-old male who presented with non-blanchable purpura involving the ankles, knees, and palms. The patient had idiopathic pulmonary fibrosis (IPF), for which he had been on long-term oxygen therapy and chronic corticosteroids. He was recently started on Bactrim DS (trimethoprim-sulfamethoxazole double strength) for prophylaxis of pneumocystis pneumonia. After a meticulous workup, including a skin biopsy, the causative agent of the LCV was established to be Bactrim DS, and the event was likely triggered by superimposed acute stress of sepsis secondary to UTI and bacteremia. There were several diagnostic dilemmas due to the ongoing chronic medical conditions; however, the occurrence of LCV while being on chronic corticosteroids was concerning as it should have prevented such an untoward occurrence. Eventually, the presentation subsided past an increase in the dose of corticosteroids and discontinuation of Bactrim DS. This raises concern regarding either the dose-dependent immunosuppressive effects of corticosteroids or deficits in our current understanding of the mechanism of action. Additionally, it necessitates further exploration into the causes of LCV and a thorough understanding of its pathogenesis.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention

